Türkiye'de ve Dünyada Sık Karşılaşılan Kanserler ve Hemşirelerin Kanseri Önlemedeki Rolü

Abstract

Kanser, küresel ölçekte en önemli bulaşıcı olmayan sağlık sorunlarından biri olup, 2020 yılında 19,3 milyon yeni vaka ve 10 milyon ölüm ile büyük bir yük oluşturmaktadır. Gelişmiş ülkelerde erken tanı ve farkındalık düzeyi daha yüksekken, gelişmekte olan ülkelerde kanser genellikle ileri evrelerde tespit edilmektedir. Türkiye’de akciğer, meme ve kolorektal kanserler en sık görülen kanser türleri arasında yer almaktadır. Hemşireler, kanser risk faktörlerini belirleme, toplum bilincini artırma, erken tanı ve koruyucu bakım sağlama konularında hayati bir rol üstlenmektedir. Tarama süreçlerindeki koordinasyon, hasta eğitimi ve savunuculuk gibi sorumlulukları, kanserle mücadelede kritik öneme sahiptir. Bu rollerin güçlendirilmesi, kanserin önlenmesi ve kontrolünde temel bir strateji olarak değerlendirilmektedir. Bu bilgiler ışığında, bu derlemenin amacı, kanserin küresel ve ulusal düzeydeki yaygınlığını incelemek, en sık karşılaşılan kanser türlerini analiz etmek ve hemşirelerin kanser önleme ve tarama süreçlerindeki rollerini değerlendirmektir.

Keywords

• Sık görülen klanserler
• Kanserden korunma
• Hemşire

Project Number

2024; 13(3)

Cancers Frequently Encountered in Türkiye and Worldwide and the Role of Nurses in Cancer Prevention

Abstract

Cancer is recognized as one of the most significant non-communicable diseases health concerns on a global scale posing a substantial burden. In 2020, it accounted for 19.3 million newly diagnosed cases and 10 million fatalities worldwide. While early diagnosis and awareness are more prevalent in developed countries, cancer is often detected at advanced stages in developing nations. In Turkey, lung, breast, and colorectal cancers are among the most common types. Nurses play a vital role in identifying cancer risk factors, raising public awareness, and providing early diagnosis and preventive care. Their responsibilities in screening processes, including coordination, patient education, and advocacy, are critical in the fight against cancer. Strengthening these roles is considered an essential strategy for cancer prevention and control. Based on this information, the aim of this review is to analyze the global and national prevalence of cancer, analyze the most common cancer types, and evaluate the roles of nurses in cancer prevention and screening processes.

Keywords

• Neoplasms
• Neoplasm Prevention
• Early Detection of Cancer
• Nurses

Project Number

2024; 13(3)

References

1. WHO. Cancer [Internet]. Geneva: World Health Organization; 2024 [Erişim tarihi: 9 Ekim 2024]. Erişim adresi: https://www.who.int/health-topics/cancer#tab=tab_1
2. National Cancer Institute. What is cancer? [Internet]. [Erişim tarihi: 9 Ekim 2024]. Erişim adresi: https://www.cancer.gov/about-cancer/understanding/what-is-cancer#definition.
3. Kumar K, Mohammadnezhad M. Once you get cancer you die. There is no way to get saved from cancer. A qualitative exploration of patients perceptions towards cancer in Fiji. PLoS One. 2022;17(12). doi:10.1371/journal.pone.0277970
4. Chen W, Sun K, Zheng R, Zeng H, Zhang S, Xia C, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1-12. doi:10.21147/j.issn.1000-9604.2018.01.01
5. Soerjomataram I, Bray F. Planning for tomorrow: Global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663-72.
6. Esplen MJ, Hunter J, Maheu C, Rosberger Z, Wong J, McGillicuddy P, Secord S, Blacker S, Green E, Toner B, Li J, Dobson K. de Souza interprofessional practice cancer competency framework. Supportive care in cancer: Official Journal of The Multinational Association of Supportive Care in Cancer. 2020;28(2):797-808. doi:10.1007/s00520-019-04823-z
7. WHO. GLOBOCAN 2020: World fact sheet. International Agency for Research on Cancer; 2024. [Erişim tarihi: 4 Haziran 2024]. Erişim adresi: https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf
8. WHO. GLOBOCAN 2020: Turkey fact sheet. International Agency for Research on Cancer; 2024. [Erişim tarihi: 4 Haziran 2024]. Erişim adresi: https://gco.iarc.who.int/media/globocan/factsheets/populations/792-turkiye-fact-sheet.pdf

9. Irmak Z, Tanrıverdi Ö, Ödemiş H, Uysal DD. Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey. Complement Ther Med. 2019;44:143-50.
10. Ergin I. Dünyada ve Türkiye'de güncel kanser istatistikleri. Turkiye Klinikleri Public Health Nurs-Spec Top. 2021;7(2):6-10.
11. Deniz EB. Kanser Epidemiyolojisi. Turkey Health Literacy Journal. 2022;3(2):102-11.
12. Doğan D, Yurttagül SM. İmmünoterapi gören akciğer kanserli hastalarda diyet danışmanlığının rolü. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi. 2024;15(1):165-73.
13. Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn). 2021;25(1):45-52.
14. Lam DC, Liam CK, Andarini S, Park S, Tan DSW, Singh N, Jang SH, Vardhanabhuti V, Ramos AB, Nakayama T, Nhung NV, Ashizawa K, Chang YC, Tscheikuna J, Van CC, Chan WY, Lai YH, Yang PC. Lung cancer screening in Asia: An expert consensus report. Journal of Thoracic Oncology: Official Publication of The International Association for the Study of Lung Cancer. 2023;18(10):1303-1322. doi:10.1016/j.jtho.2023.06.014
15. WHO. Breast cancer. [Internet]. [Erişim tarihi: 15 Ekim 2024]. Erişim adresi: https://www.who.int/news-room/fact-sheets/detail/breast-cancer
16. Houghton SC, Hankinson SE. Cancer progress and priorities: Breast cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(5):822-44.
17. Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: Presentation, investigation and management. Br J Hosp Med. 2022;83(2):1-7.
18. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72(6):524-41.
19. US Preventive Services Task Force. Screening for breast cancer. JAMA. 2024;331(22):1973-4.
20. Lewandowska A, Rudzki G, Lewandowski T, Stryjkowska-Gora A, Rudzki S. Risk factors for the diagnosis of colorectal cancer. Cancer Control. 2022;29:10732748211056692. doi:10.1177/10732748211056692
21. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):101174.
22. Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel). 2021;13(9):2025.
23. Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-54.
24. Patel RK, Rahman S, Schwantes IR, Bartlett A, Eil R, Farsad K, Fowler K, Goodyear SM, Hansen L, Kardosh A, Nabavizadeh N, Rocha FG, Tsikitis VL, Wong MH, Mayo SC. Updated management of colorectal cancer liver metastases: Scientific advances driving modern therapeutic innovations. Cellular and Molecular Gastroenterology and Hepatology. 2023;16(6):881-894. doi:10.1016/j.jcmgh.2023.08.012
25. Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38-52.
26. International Agency for Research on Cancer. Prostate fact sheet [Internet]. Lyon: IARC; 2020 [Erişim tarihi: 15 Ekim 2024]. Erişim adresi: https://gco.iarc.who.int/media/globocan/factsheets/cancers/27-prostate-fact-sheet.pdf
27. Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877-92.
28. International Agency for Research on Cancer. Prostate fact sheet [Internet]. Lyon: IARC; 2020 [Erişim tarihi: 15 Ekim 2024]. Erişim adresi: https://gco.iarc.who.int/media/globocan/factsheets/cancers/27-prostate-fact sheet.pdf
29. Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022;27(17):5730.
30. Barsouk A, Padala SA, Vakiti A, Mohammed A, Saginala K, Thandra KC, et al. Epidemiology, staging and management of prostate cancer. Med Sci (Basel). 2020;8(3):28.
31. Etemadi A, Safiri S, Sepanlou SG, Ikuta K, Bisignano C, Shakeri R, et al. 195 ülkede mide kanserinin küresel, bölgesel ve ulusal yükü, 1990–2017: 2017 Küresel Hastalık Yükü çalışması için sistematik bir analiz. Lancet Gastroenterol Hepatol. 2020;5(1):42-54.
32. Poorolajal J, Moradi L, Mohammadi Y, Cheraghi Z, Gohari-Ensaf F. Risk factors for stomach cancer: A systematic review and meta-analysis. Epidemiol Health. 2020;42:e2020004. doi:10.4178/epih.e2020004
33. Entezam M, Sanaei MJ, Mirzaei Y, Mer AH, Abdollahpour-Alitappeh M, Azadegan-Dehkordi F, Bagheri N. Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach. Life Sciences. 2023;318:121459. doi:10.1016/j.lfs.2023.121459
34. Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187-203. doi:10.3748/wjg.v28.i12.1187
35. International Agency for Research on Cancer. Stomach fact sheet [Internet]. Lyon: IARC; 2020 [Erişim tarihi: 15 Ekim 2024]. Erişim adresi: https://gco.iarc.who.int/media/globocan/factsheets/cancers/7-stomach-fact-sheet.pdf
36. International Agency for Research on Cancer. Cervix uteri fact sheet [Internet]. Lyon: IARC; 2020 [Erişim tarihi: 15 Ekim 2024]. Erişim adresi: https://gco.iarc.who.int/media/globocan/factsheets/cancers/23-cervix-uteri-fact-sheet.pdf
37. Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2020;32(6):720-8. doi:10.21147/j.issn.1000-9604.2020.06.05
38. Olsson Möller U, Beck I, Rydén L, Malmström M. A comprehensive approach to rehabilitation interventions following breast cancer treatment: A systematic review of systematic reviews. BMC Cancer. 2019;19(1):472. doi:10.1186/s12885-019-5648-7
39. Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021;155:28-44.
40. Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: past, present, and future. Sex Med Rev. 2020;8(1):28-37.
41. Ziegler E, Slotnes-O'Brien T, Peters MDJ. Cancer screening and prevention in the transgender and gender diverse population: Considerations and strategies for advanced practice nurses. Seminars in Oncology Nursing. 2024;40(3):151630. doi:10.1016/j.soncn.2024.151630
42. Liebermann E, Sego R, Vieira D, Cheng Q, Xu B, Arome M, Azevedo A, Ginsburg O, So WKW. Roles and activities of nurses in cancer prevention and early detection in low- and middle-income countries: A scoping review. Asia-Pacific Journal of Oncology Nursing. 2023;10(7):100242. doi:10.1016/j.apjon.2023.100242
43. Dike S, McGowan T. Environmental risk factors: The role of oncology nurses in assessing and reducing the risk for exposure. Clinical Journal of Oncology Nursing. 2020;24(5):31-38. doi:10.1188/20.CJON.S2.31-38
44. Çelikkanat Ş, Güngörmüş Z. Meme kanseri risk faktörlerinin değerlendirilmesi ve riskli kadına hemşirelik yaklaşımı. International Journal of Social and Humanities Sciences Research (JSHSR). 2019;6(46):4023-4031.
45. Leslie NS. Role of the nurse practitioner in breast and cervical cancer prevention. Cancer Nursing. 1995;18(4):251-257.
46. Benito L, Binefa G, Lluch T, Vidal C, Milà N, Puig M, Roldán J, Garcia M. Defining the role of the nurse in population-based cancer screening programs. Clinical Journal of Oncology Nursing. 2014;18(4):E77-E83. doi:10.1188/14.CJON.E77-E83
47. Grant AM, Signorelli C, Taylor N, de Graves S, Tucker KM, Cruickshank M. Models of care and the advanced practice nurse role in caring for children and adolescents with a cancer predisposition syndrome: A scoping review protocol. JBI Evidence Synthesis. 2024;22(5):864-873. doi:10.11124/JBIES-23-00074
48. Monas L, Toren O, Uziely B, Chinitz D. The oncology nurse coordinator: Role perceptions of staff members and nurse coordinators. Israel journal of health policy research. 2017;6:1-11. doi:10.1186/s13584-017-0186-8
49. Özkaraman Ayşe, Uzgör Füsun. Kanserden korunmada yenilikçi bir girişim: Hemşire koçluğu. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Dergisi, 2021;9(3):1140-1153. doi:10.33715/inonusaglik.825499
50. Foster T. The importance of three-dimensional total body photography and the role of the dermatology nurse in the prevention of melanoma in high-risk patients. J Dermatol Nurses Assoc. 2024;16(2):56-59. doi:10.1097/JDN.0000000000000780
51. Martínez C, Castellano Y, Fu M, Riccobene A, Enríquez M, Narváez M, Saura J, Feliu A, Fernández E. Long-term effectiveness of a nurse-led smoking cessation clinic at a comprehensive cancer center. Journal of Nursing Scholarship: An Official Publication of Sigma Theta Tau International Honor Society of Nursing. 2023;55(3):681-691. doi:10.1111/jnu.12891
52. Abu Awwad D, Hossain SZ, Mackey M, Brennan P, Adam S. Optimising awareness and knowledge of breast cancer screening for nurses through train-the-trainer workshops. Journal of Cancer Education: The Official Journal of The American Association for Cancer Education. 2022;37(4):1209-1219. doi:10.1007/s13187-020-01942-8
53. Hashemi N, Bahrami M, Tabesh E, Arbon P. Nurse's roles in colorectal cancer prevention: A narrative review. Journal of Prevention. 2022;43(6):759-782. doi:10.1007/s10935-022-00694-z
54. Özkaraman A, Uzgör F. Kanserden korunmada yenilikçi bir girişim: Hemşire koçluğu. İnönü Üniversitesi Sağlık Hizmetleri Meslek Yüksekokulu Dergisi. 2021;9(3):1140-1153.
55. Velioğlu E, Yıldız H. Jineko-onkoloji hemşireliği ve rolleri. Türk Jinekolojik Onkoloji Dergisi. 2023;23(1):35-40.
56. Kavala A, Yıldırım D. Böbrek Kanseri ve Hemşirelik Yönetimi/Kidney Cancer and Nursing Management. Journal of Nephrology Nursing. 2023;18(1):37-44 doi:10.47565/ndthdt.2023.66
57. Kabacaoğlu C, Karaca A. Meme kanserinde birincil ve ikincil korunma önlemlerine ilişkin ebe ve hemşirenin rolü. JAREN 2020;6(1):179-86. doi:10.5222/jaren.2020.69885